What’s New

Expanding Our Eucerin Partnership to Albania

In 2026, Pharma One became Asgeto Albania, marking a new chapter in the Group’s healthcare development and strengthening its regional identity under the Asgeto name.

Building on our long-standing and successful partnership with Biersdorf’s for Eucerin exclusive distribution in Kosovo, in 2026 the relationship reached an important new milestone with Asgeto Albania securing the same contract for the Albanian market.

The expansion reflects the trust and confidence built through years of cooperation in Kosovo, where our market knowledge, distribution capabilities and commitment to long-term brand development have created a strong foundation for growth.

As Pharma One evolves into Asgeto Albania, the addition of Eucerin further strengthens our presence in the Albanian healthcare and dermocosmetics sector and demonstrates our ability to successfully develop trusted international brands across regional markets.

Asgeto × Eucerin — a trusted partnership growing beyond borders.

Expanding into Beauty with Noelle

As part of our continued portfolio diversification, 1AMD is expanding into the beauty and cosmetics sector through its partnership with Noelle, an Austrian-Croatian brand known for its playful, modern approach to makeup brushes, beauty tools and accessories.

Noelle combines functionality, contemporary design and accessible beauty, creating products that bring color and personality to everyday beauty routines. Its fresh brand identity and broad range of makeup accessories make it particularly relevant to a new generation of beauty consumers.

Through this partnership, 1AMD is taking another step beyond its traditional categories and into the growing beauty and personal care market, using its distribution expertise and local market knowledge to develop Noelle’s presence in Kosovo and Albania.

We love their MOTO — You weren’t born to blend in!

New Partnership with Biosphere Corporation

1AMD is proud to announce its strategic partnership with Biosphere Corporation, an international manufacturer and supplier of household and personal care products with a growing global presence.

Established in 2023, the partnership began with the introduction of Vortex as a pilot brand in the market. Following the positive development of this initial cooperation, the partnership has created opportunities to expand the portfolio with additional brands from the Biosphere Corporation family.

The partnership reflects 1AMD’s strategy of working with strong international partners and developing brands through local market expertise, professional distribution and long-term investment.

1AMD × Biosphere Corporation — building international brands through strong local partnerships.

Environmental Stewardship

Sustainability is an important part of how we think about long-term growth. Across our companies, we have invested in solar energy as part of our commitment to reducing our environmental footprint and operating more responsibly.

By integrating renewable energy into our operations, we are reducing reliance on conventional energy sources while investing in technologies that support a more sustainable future.

As our family business continues to grow and expand into new industries, we remain committed to combining business development, responsible investment and environmental awareness—creating long-term value while minimizing our impact on the environment.

Curalin – a better life story

In 2023, Farmix obtained the rights to launch Curalin, a revolutionary supplement for managing Type 2 diabetes, containing nine natural ingredients, backed by two published clinical trials, and endorsed by Dr. Itamar Raz, a respected international endocrinologist. Notably, Farmix’s professionalism has led both the suppliers in Israel and partner in Serbia to choose GAK as their distributor for North Macedonia. This decision was influenced by GAK’s strong connections and relations with key pharmaceutical profiles

Latest Milestones

In Albania, through its collaboration with Pharma One, GAK has contributed to expanding access to products from leading international pharmaceutical companies, including KRKA, Alkaloid and Novo Nordisk. These partnerships reflect the Group’s long-term strategy of making healthcare a core pillar of its business development.

At the same time, GAK & Partners successfully established a strong retail presence in Slovenia despite entering during the challenging COVID period. Building on this experience, the Group expanded operations into Greece, continuing its strategy of developing strong partnerships and building a broader presence across Southeast European markets.

Healthcare, trusted partnerships and regional growth remain at the heart of GAK’s long-term strategy.